Palvella Therapeutics director George M. Jenkins disposes of $3.58m PVLA stock
A large sale of Palvella Therapeutics stock by Director George M. Jenkins was executed on October 12-14, 2026. The Iowa-based company's stock had shown impressive growth, with a 66.73% return over the previous year. However, it has since declined about 6% in recent trades. Jenkins sold 27,000 shares, valued between $121.14 and $136.44 each, near the stock's current price of $122.58.
These transactions were part of a pre-established Rule 10b5-1 trading plan, approved by the company's insider trading policy. After the sale, Jenkins directly holds 132,616 shares, with an additional 13,516 shares indirectly held by the Eagles Mere Air Museum Foundation.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
